Biote (BTMD) Restructuring Costs (2021 - 2022)
Biote (BTMD) posted quarterly Restructuring Costs of $1.2 million for Q1 2022, up 1932.73% year-over-year from $58560.0 in Q1 2021, and down 49.15% on a QoQ basis from $2.3 million in Q4 2021.
Biote (BTMD) Restructuring Costs (2021 - 2022) Analysis & Trends
Biote (BTMD) has reported Restructuring Costs for 2 consecutive years, with $1.2 million the latest figure, recorded in Q1 2022.
- In Q1 2022, Restructuring Costs rose 1932.73% year-over-year to $1.2 million; the TTM figure through Mar 2022 stood at $4.3 million (changed N/A YoY), while the FY2021 annual figure was $3.1 million, changed N/A from the prior year.
- Restructuring Costs came in at $1.2 million for Q1 2022 at Biote, down from $2.3 million in the prior quarter.
- The five-year high for Restructuring Costs was $2.3 million in Q4 2021, with the low at $58560.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn |
| 10 | Biote | 5,970.00 | 2.82 Mn | 30.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 262,487.00 |
| Jun 30, 2021 | 459,768.00 |
| Mar 31, 2021 | 58,560.00 |